Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Endocrinol ; 156(3): 583-90, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9582515

ABSTRACT

Glucose infusion into rats has been shown to sensitize/desensitize insulin secretion in response to glucose. In pancreatic islets from glucose-infused rats (GIR) (48 h, 50%, 2 ml/h) basal insulin release (2.8 mmol/l glucose) was more than fourfold compared with islets from saline-infused controls and the concentration-response curve for glucose was shifted to the left with a maximum at 11.1 mmol/l. The concentration-response curve for 45Ca2+ uptake was also shifted to the left in islets from GIR with a maximum at 11.1 mmol/l glucose. Starting from a high basal level at 2.8 mmol/l glucose KCl produced no insulin release or 45Ca2+ uptake in islets from GIR. Islets from GIR exhibited a higher ATP/ADP ratio in the presence of 2.8 mmol/l glucose and marked inhibition of 86Rb+ efflux occurred even at 3 mmol/l glucose. Moreover, in islets from GIR the redox ratios of pyridine nucleotides were increased. On the other hand insulin content was reduced to about 20%. The data suggest that a 48-h glucose infusion sensitizes glucose-induced insulin release in vitro in concentrations below 11.1 mmol/l. This may, at least in part, be due to enhanced glucose metabolism providing increased availability of critical metabolic factors including ATP which, in turn, decrease the threshold for depolarization and therefore calcium uptake. Calcium uptake may then be further augmented by elevation of the redox state of pyridine nucleotides.


Subject(s)
Calcium/metabolism , Glucose/pharmacology , Insulin/metabolism , Islets of Langerhans/metabolism , Adenosine Diphosphate/metabolism , Adenosine Triphosphate/metabolism , Animals , Female , Glucose/administration & dosage , Insulin Secretion , Islets of Langerhans/drug effects , NAD/metabolism , NADP/metabolism , Oxidation-Reduction , Rats , Rats, Wistar , Rubidium Radioisotopes
2.
Mol Endocrinol ; 11(5): 619-29, 1997 May.
Article in English | MEDLINE | ID: mdl-9139805

ABSTRACT

Opening of dihydropyridine-sensitive voltage-dependent L-type Ca2+-channels (LTCCs) represents the final common pathway for insulin secretion in pancreatic beta-cells and related cell lines. In insulin-secreting cells their exact subunit composition is unknown. We therefore investigated the subunit structure of (+)-[3H]isradipine-labeled LTCCs in insulin-secreting RINm5F cells. Using subunit-specific antibodies we demonstrate that alpha1C subunits (199 kDa, short form) contribute only a minor portion of the total alpha1 immunoreactivity in membranes and partially purified Ca2+-channel preparations. However, alpha1C forms a major constituent of (+)-[3H]isradipine-labeled LTCCs as 54% of solubilized (+)-[3H]isradipine-binding activity was specifically immunoprecipitated by alpha1C antibodies. Phosphorylation of immunopurified alpha1C with cAMP-dependent protein kinase revealed the existence of an additional 240-kDa species (long form), that remained undetected in Western blots. Fifty seven percent of labeled LTCCs were immunoprecipitated by an anti-beta-antibody directed against all known beta-subunits. Isoform-specific antibodies revealed that these mainly corresponded to beta1b- and beta3-subunits. We found beta2- and beta4-subunits to be major constituents of cardiac and brain L-type channels, respectively, but not part of L-type channels in RINm5F cells. We conclude that alpha1C is a major constituent of dihydropyridine-labeled LTCCs in RINm5F cells, its long form serving as a substrate for cAMP-dependent protein kinase. beta1b- and beta3-Subunits were also found to associate with L-type channels in these cells. These isoforms may therefore represent biochemical targets for the modulation of LTCC activity in RINm5F cells.


Subject(s)
Calcium Channels/metabolism , Insulin/metabolism , Islets of Langerhans/metabolism , Calcium Channels/analysis , Humans , Insulin Secretion , Insulinoma , Phosphorylation , Tumor Cells, Cultured
3.
Endocrinology ; 136(12): 5363-9, 1995 Dec.
Article in English | MEDLINE | ID: mdl-7588283

ABSTRACT

Nitric oxide (NO) is considered to contribute to the impairment of B cell function in insulin-dependent diabetes mellitus. The effects of compounds that release NO were tested on the membrane potential and ionic currents of mouse pancreatic B cells using intracellular microelectrodes and the whole-cell patch-clamp technique. S-Nitrosocysteine led to a concentration-dependent reduction of electrical activity induced by 15 mM glucose. At a concentration of 1 mM, S-nitrosocysteine cause a hyperpolarization of the plasma membrane with complete suppression of electrical activity. In about half of the cells tested, electrical activity reappeared during treatment with S-nitroso-cysteine or after wash-out. However, in the other cells the hyperpolarization was followed by a slow depolarization and electrical activity did not reappear. The perforated-patch whole-cell K+ATP current first increased and subsequently decreased again during exposure to 1 mM S-nitroso-cysteine. With 0.1 and 0.01 mM S-nitroso-cysteine, only the rise of the current amplitude was observed. S-nitroso-cysteine (1 mM) almost completely abolished the current through voltage-dependent Ca2+ channels (measured with Ba2+ as charge carrier). Like S-nitroso-cysteine, 100 microM sodium-nitroprusside, another donor, evoked a marked hyperpolarization of the membrane potential that was at least in part reversible. To further ascertain that the effect of S-nitroso-cysteine was mediated by NO, we tested the decomposition products of S-nitroso-cysteine. Nitrite and denitrosylated S-nitroso-cystein (1 mM) did not alter electrical activity of B cells, whereas cysteine (1 mM) caused a slight depolarization. It is concluded that exogenous NO evokes rapid changes of B cell function by influencing the activity of ion channels.


Subject(s)
Calcium Channels/drug effects , Islets of Langerhans/physiology , Nitric Oxide/physiology , Potassium Channels/drug effects , S-Nitrosothiols , Animals , Cysteine/analogs & derivatives , Cysteine/pharmacology , Female , Islets of Langerhans/drug effects , Membrane Potentials/drug effects , Mice , Nitroprusside/pharmacology
4.
Naunyn Schmiedebergs Arch Pharmacol ; 346(5): 527-31, 1992 Nov.
Article in English | MEDLINE | ID: mdl-1335126

ABSTRACT

In order to characterize the voltage-dependent Ca2+ channels of insulin secretory RINm5F cells, we have studied the binding of the dihydropyridine (DHP) type Ca2+ antagonist PN 200-110 and its effect on insulin release. In the membrane preparation from RINm5F cells [3H]-(+)-PN 200-110 bound to a high affinity binding site in a stereoselective manner (KD: 7.0 nM, Bmax: 858 fmol/mg protein). The benzothiazepine type Ca2+ antagonist D-cis-diltiazem increased the binding of [3H]-(+)-PN 200-110 in a temperature-dependent manner. The phenylalkylamine-type Ca2+ antagonist verapamil decreased PN binding with an IC50 of 100 microM. (+)-PN 200-110 inhibited KCl-(25 mM)-induced insulin release (IC50 = 10 nM). Effects on binding and hormone release occurred over comparable concentration ranges: 1 microM PN 200-110 produced 100% displacement and totally abolished depolarization-mediated insulin release. The N-type Ca(2+)-antagonist omega-conotoxin showed no effect on KCl-induced insulin release. The data suggest that in RINm5F cells only L-type Ca2+ channels are involved in the mechanism of depolarization-mediated insulin release.


Subject(s)
Calcium Channels/metabolism , Calcium/metabolism , Insulin/metabolism , Insulinoma/metabolism , Pancreatic Neoplasms/metabolism , Potassium Chloride/pharmacology , omega-Conotoxins , Animals , Calcium Channels/drug effects , Diltiazem/pharmacology , Insulin Secretion , Isradipine/pharmacology , Kinetics , Peptides, Cyclic/pharmacology , Radioimmunoassay , Rats , Stereoisomerism , Temperature , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...